Who are Evolutionary Genomics's investors?

Evolutionary Genomics's investors include Rockies Venture Club.

How much funding has Evolutionary Genomics raised?

Evolutionary Genomics has disclosed $6.4M raised across 4 rounds.

Where is Evolutionary Genomics headquartered?

Evolutionary Genomics is headquartered in Castle Rock, US.

Evolutionary Genomics

Castle Rock, US · Nevada corporation · 1 known investors

Evolutionary Genomics identifies and develops crop resistance genes from wild plant relatives to combat fungal diseases and pests. The company uses genomic tools to enable disease-resistant varieties in bananas, soybeans, tomatoes, and cotton for commercial agriculture.

AgTechBiotech

Founders & leadership

Steve Bryan WarneckeExecutive

Walter MessierNamed on SEC filing

Steve B WarneckeNamed on SEC filing

Board

Mark BoggessBoard director

Virginia OrndorffBoard director

Investors · 1

Rockies Venture ClubDenver · $100K – $500K

Reported raises · per SEC filings

Form D private placements

$6.4M disclosed across 4 rounds · 2014–2022

▶$1MraisedMay 2022 · 17 investors · Agriculture

Rule 506(b)

Officers, directors & promoters on the filing

Walter MessierExecutive Officer
Virginia OrndorffDirector
Mark BoggessDirector
Steve Bryan WarneckeExecutive Officer, Director

Amount sold: $1M
Minimum investment: $10K
First sale: Mar 2022
Incorporated: Corporation, Nevada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$490KraisedMay 2019 · 4 investors · Agriculture

Rule 506(b)

Officers, directors & promoters on the filing

Mark BoggessDirector
Walter MessierExecutive Officer
Virginia OrndorffDirector
Steve Bryan WarneckeExecutive Officer

Offering amount: $1.1M
Amount sold: $490K
Minimum investment: $25K
First sale: May 2019
Incorporated: Corporation, Nevada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.9MraisedMar 2016 · 25 investors · Agriculture

Rule 506(b)

Officers, directors & promoters on the filing

Mark BoggessDirector
Steve Bryan WarneckeExecutive Officer, Director
Walter MessierExecutive Officer
Virginia OrndorffDirector

Offering amount: $3.1M
Amount sold: $2.9M
Minimum investment: $20K
First sale: Feb 2016
Incorporated: Corporation, Nevada
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMar 2014 · 21 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Walter MessierExecutive Officer
Virginia OrndorffDirector
Steve B WarneckeExecutive Officer, Director
Mark BoggessDirector

Offering amount: $4.5M
Amount sold: $2M
Minimum investment: $10K
First sale: Mar 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Oup3 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.

Companies competing with Evolutionary Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Evolutionary Genomics do?: Evolutionary Genomics identifies and develops crop resistance genes from wild plant relatives to combat fungal diseases and pests. The company uses genomic tools to enable disease-resistant varieties in bananas, soybeans, tomatoes, and cotton for commercial agriculture.
Who are Evolutionary Genomics's investors?: Evolutionary Genomics's investors include Rockies Venture Club.
How much funding has Evolutionary Genomics raised?: Evolutionary Genomics has disclosed $6.4M raised across 4 rounds.
Where is Evolutionary Genomics headquartered?: Evolutionary Genomics is headquartered in Castle Rock, US.